captopril has been researched along with Left Ventricular Dysfunction in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 26 (29.55) | 18.2507 |
2000's | 50 (56.82) | 29.6817 |
2010's | 12 (13.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, LY; Jin, KK; Qiu, XX; Yao, LP; Zhao, J | 1 |
Ambrosio, G; Ambrosioni, E; Bacchelli, S; Borghi, C; Cicero, AF; Esposti, DD; Omboni, S; Vinereanu, D; Zava, D | 1 |
Califf, R; Claggett, B; Køber, L; Lam, CS; Lewis, E; Liu, J; McEntegart, M; McMurray, JJ; Pfeffer, M; Rouleau, J; Skali, H; Solomon, S; Velazquez, E | 1 |
Hagendorff, A; Hawlitschek, C; Rabald, S; Rassler, B; Zimmer, HG; Zimmer, J | 1 |
Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Omboni, S; Vinereanu, D | 3 |
Bauer, R; Blain, A; Bushby, K; MacGowan, GA; Straub, V | 1 |
Al-Khatib, SM; Califf, RM; McMurray, JJ; Pfeffer, MA; Piccini, JP; Pieper, K; Solomon, SD; Van de Werf, F; Velazquez, EJ; Zhang, M | 1 |
Hara, Y; Hoshino, Y; Kosaka, N; Okada, M; Yamawaki, H | 1 |
Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, J; Signorovitch, JE; Solomon, SD; Swedberg, K; Thune, JJ; Velazquez, E | 1 |
Amigoni, M; Califf, R; Køber, L; Levine, RA; McMurray, JJ; Meris, A; Pfeffer, MA; Solomon, SD; Thune, JJ; Velazquez, E; Verma, A | 1 |
Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Vinereanu, D | 1 |
Ahmed, A; Allman, RM; Bodner, EV; DeLong, JF; Howard, G | 1 |
Colier, WN; Hoefnagels, WH; Jansen, RW; Mehagnoul-Schipper, DJ; Verheugt, FW | 1 |
Danchin, N | 1 |
Braunwald, E; Goldman, S; Lee, D; Pfeffer, MA; Plappert, T; Rouleau, JL; St John Sutton, M | 1 |
Lapointe, N; Pourdjabbar, A; Rouleau, JL | 1 |
Califf, RM; Edwards, S; Gallo, P; Henis, M; Kober, L; Leimberger, JD; Maggioni, AP; McMurray, JV; Pfeffer, MA; Rouleau, JL; Sellers, MA; Swedberg, K; Van de Werf, F; Velazquez, EJ; White, HD | 1 |
Berna, G; Celeste, F; Guazzi, M; Maltagliati, A; Muratori, M; Pepi, M; Susini, F; Tamborini, G | 1 |
Deswal, A; Mann, DL | 1 |
Califf, RM; Edwards, S; Henis, M; Køber, L; Leimberger, JD; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Sellers, MA; Solomon, SD; Swedberg, K; Van de Werf, F; Velazquez, EJ; White, H; Zelenkofske, S | 1 |
McAnulty, JH | 1 |
Liebson, PR | 1 |
Piña, IL | 1 |
Geltman, EM; Kenchaiah, S; Lamas, GA; Parker, JO; Pfeffer, MA; Plappert, T; Rouleau, JL; Sasson, Z; Solomon, SD; St John Sutton, M | 1 |
Hasenfuss, G | 1 |
Bernstein, V; Braunwald, E; Brown, EJ; Dagenais, GR; Davis, BR; Gordon, D; Kenchaiah, S; Lamas, GA; Pfeffer, MA; Rouleau, JL; Steingart, RM; Sussex, B | 1 |
Aguilar, D; Belenkov, YN; Califf, RM; Diaz, R; Francis, GS; Henis, M; Køber, L; Leimberger, JD; McMurray, JJ; O'Connor, CM; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Varshavsky, S; Velazquez, EJ | 1 |
Nguyen, A; Sharma, S | 1 |
Falcão, LM; Pinto, F; Ravara, L; van Zwieten, PA | 1 |
Finn, JI; Koelling, TM; Rangaswamy, C | 1 |
Braunwald, E; Flaker, GC; Goldman, S; Hennekens, CH; Jiménez-Navarro, M; Lamas, GA; Murcia, AM; Pfeffer, MA; Rouleau, JL; Skali, H | 1 |
Dickstein, K; Lehto, M; Nieminen, MS; Snapinn, S; Swedberg, K | 1 |
Anavekar, NS; Arnold, JM; Barvik, S; Bourgoun, M; Califf, RM; Ghali, JK; Khrakovskaya, M; McMurray, JV; Pfeffer, MA; Schwartz, Y; Skali, H; Solomon, SD; Velazquez, EJ; Warnica, JW | 1 |
Arutiunov, GP; Belenkov, IuN; Glezer, MG; Matrynov, AI; Moiseev, VS; Pozdniakov, IuM; Storozhakov, GI; Striuk, RI; Tereshchenko, SN; Zadionchenko, VM | 1 |
Allsbrook, JS; Califf, RM; Masselink, LE; McMurray, JJ; Pfeffer, MA; Radeva, JI; Reed, SD; Schulman, KA; Sellers, MA; Velazquez, EJ; Weinfurt, KP | 1 |
Aylward, PE; Barvik, S; Califf, RM; Dalby, AJ; Huang, Z; Marin-Neto, JA; McMurray, JJ; Murin, J; Nordlander, RO; Pfeffer, MA; van Gilst, WH; Weaver, WD; White, HD; Zannad, F | 1 |
Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
Califf, RM; Diaz, R; Ertl, G; Køber, L; Leimberger, JD; Maggioni, AP; Mareev, V; McMurray, JJ; Opolski, G; Pfeffer, MA; Rouleau, JL; Solomon, SD; Swedberg, K; Van de Werf, F; Velazquez, EJ; Zannad, F; Zelenkofske, S | 1 |
Califf, RM; Diaz, R; Kober, L; Maggioni, AP; Mareev, V; McMurray, JJ; Murin, J; Reed, SD; Schulman, KA; Van de Werf, F; Velazquez, EJ; White, HD | 1 |
Białkowski, J; Dziubek, B; Kalarus, Z; Kukulski, T; Lenarczyk, A; Rycaj, J; Szulik, M | 1 |
Aylward, PG; Califf, RM; Kober, L; McMurray, JJ; Pfeffer, MA; Pieper, KS; Skali, H; Solomon, SD; Stephenson, K; Van de Werf, F; Velazquez, EJ; White, HD | 1 |
Ott, P | 1 |
Califf, RM; Howlett, J; Kober, L; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Signorovitch, J; Solomon, SD; Thune, JJ; Velazquez, EJ; Zelenkofske, S | 1 |
Anavekar, NS; Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, E; White, H | 1 |
Havranek, EP | 1 |
Califf, RM; Francis, GS; Huang, Z; Lewis, EF; McMurray, JJ; Pfeffer, MA; Prisant, LM; Thomas, KL; Velazquez, EJ; Weaver, WD | 1 |
Carlsson, J; Obergassel, L; Tebbe, U | 1 |
McMurray, J | 1 |
Flaker, GC; Gersh, BJ; Lamas, GA; Mitchell, G; Moyé, L; Pfeffer, MA; Rouleau, JL; Rutherford, JD; Smith, SC; Wun, CC | 1 |
Arsencio, SR; Barretto, AC; Bodanese, LC; Marafon, LP; Oliveira Júnior, MT | 1 |
Cerimele, B; Greene, P; Reed, S; Ryan, T; Schwertschlag, U; Voelker, J; Weinberger, M | 1 |
Pfeffer, MA | 1 |
Blinston, GE; Jugdutt, BI; Jugdutt, SJ; Khan, MI | 1 |
Dambrink, JH; Kingma, JH; Peels, CH; van Gilst, WH; Verheugt, FW; Wielenga, RP | 1 |
Bayliss, J; Darasz, KH; Keegan, J; Poole-Wilson, PA; Sutton, GC; Underwood, SR | 1 |
Al, MJ; Kingma, JH; Kragten, JA; Michel, BC; Remme, WJ; van Hout, BA; van Nieuwenhuizen, R | 1 |
Amadi, A; Coats, A; Gibson, DG; Henein, MY; O'Sullivan, C | 1 |
Arnold, JM; Ciampi, A; Klein, M; Moyé, L; Pfeffer, M; Rouleau, JL; Sussex, B; Vantrimpont, P; Wun, CC | 1 |
O'Rourke, RA | 1 |
Candy, GP; Hartford, C; Norton, GR; Trifunovic, B; Tsotetsi, J; Woodiwiss, AJ | 1 |
Szucs, TD | 1 |
Davis, BR; Hager, WD; Lamas, GA; Moye, LA; Pfeffer, MA; Riba, A; Rouleau, JL; Wun, CC | 1 |
Androulakis, AE; Dernellis, J; Gialafos, JE; Kelepeshis, GA; Kyriakidis, M; Mellas, P; Triposkiadis, F | 1 |
Anning, PB; Grocott-Mason, RM; Lewis, MJ | 1 |
Humen, DP; Jugdutt, BI | 1 |
Rady, MY; Ryan, T | 1 |
Adigun, AQ; Ajayi, AA; Ajayi, OE; Sofowora, GG | 1 |
Massin, EK | 1 |
Bounhoure, JP; Dubourg, O; Guéret, P; Thuillez, C; Vahanian, A | 1 |
Gallois, H; Haïat, R; Hanania, G; Piot, O | 1 |
Chen, JJ; Chen, SF; Cherng, WJ; Lee, N; Wang, CH | 1 |
Agelopoulos, G; Alexopoulos, D; Chiladakis, JA; Karapanos, G; Manolis, AS | 1 |
Chen, SF; Cherng, WJ; Hung, MJ; Wang, CH | 1 |
Califf, RM; Velazquez, EJ | 1 |
Armstrong, PW | 1 |
Chung, ES; Lancaster, EJ; Mela, T; Meyer, TE; Norton, GR; Sprott, S; Tsotetsi, OJ; Woodiwiss, AJ | 1 |
Chen, YT; Krumholz, HM; Radford, MJ; Wang, Y | 1 |
Bässler, A; Fischer, M; Hengstenberg, C; Holmer, S; Klein, G; Löwel, H; Mayer, B; Riegger, G; Schunkert, H | 1 |
Francis, GS; Gassler, JP | 1 |
Haas, GJ | 1 |
Barretto, AC | 1 |
Charbonnier, B; Dubroca, I; Etienne, S; Normand, J; Ounnoughene, Z; Schwob, J; Vaur, L; Weber, S | 1 |
Cabrera Solé, R; Fernández-Fúnez, A; Hernández, A; Martínez, V; Solera, J | 1 |
3 review(s) available for captopril and Left Ventricular Dysfunction
Article | Year |
---|---|
[ACE inhibitor-associated interstitial lung infiltrates].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Humans; Lung; Lung Diseases, Interstitial; Middle Aged; Mitral Valve Insufficiency; Tomography, X-Ray Computed; Ventricular Dysfunction, Left | 1995 |
Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Delivery of Health Care; Economics, Pharmaceutical; Fosinopril; Heart Failure; Hospital Charges; Humans; Ventricular Dysfunction, Left | 1997 |
Management of asymptomatic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Coronary Disease; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
37 trial(s) available for captopril and Left Ventricular Dysfunction
Article | Year |
---|---|
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Pressure; Captopril; Europe; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Ventricular Dysfunction, Left | 2013 |
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Risk; Risk Factors; Sex Factors; Valsartan; Ventricular Dysfunction, Left | 2015 |
Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study.
Topics: Captopril; Demography; Drug Therapy, Combination; Endpoint Determination; Female; Hospitalization; Humans; Intention to Treat Analysis; Male; Middle Aged; Myocardial Infarction; Propensity Score; Ramipril; Survival Analysis; Time Factors; Ventricular Dysfunction, Left | 2016 |
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Death, Sudden, Cardiac; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Recurrence; Risk Factors; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2010 |
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
Topics: Age Factors; Aged; Captopril; Cause of Death; Confidence Intervals; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Risk Assessment; Severity of Illness Index; Sex Factors; Survival Analysis; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2011 |
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction.
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Echocardiography, Doppler, Color; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Monitoring, Physiologic; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Reference Values; Reproducibility of Results; Risk Assessment; ROC Curve; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling | 2012 |
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European stud
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Risk Assessment; Risk Factors; Stroke Volume; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients > or = 70 years of age with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cerebral Cortex; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Heart Rate; Hemoglobins; Humans; Male; Oxygen Consumption; Oxyhemoglobins; Postprandial Period; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiomegaly; Demography; Double-Blind Method; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Premature Complexes; Ventricular Remodeling | 2003 |
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
[AT(1) blocker for post-infarct therapy. VALIANT Study].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Survival Analysis; Syndrome; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiovascular Diseases; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Survivors; Ventricular Dysfunction, Left | 2004 |
Heart attack patients with complications. Treat with valsartan, captopril, or both?
Topics: Aged; Antihypertensive Agents; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Biphenyl Compounds; Captopril; Cardiac Output, Low; Chronic Disease; Echocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Irbesartan; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Radiography, Thoracic; Radionuclide Ventriculography; Tetrazoles; Ventricular Dysfunction, Left | 2004 |
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Captopril; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heart Function Tests; Humans; Insulin; Male; Middle Aged; Myocardial Infarction; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Captopril; Epidemiologic Methods; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Prognosis; Stroke; Ventricular Dysfunction, Left | 2005 |
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Hospitalization; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Prognosis; Stroke Volume; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
[Randomized multicenter study PRESTIGE: assessment of efficacy of perindopril as compared with captopril in patients with acute myocardial infarction with left ventricular dysfunction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Male; Myocardial Infarction; Perindopril; Ventricular Dysfunction, Left | 2005 |
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Ambulatory Care; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Costs; Global Health; Health Care Costs; Health Resources; Heart Failure; Hospital Costs; Hospitalization; Humans; Myocardial Infarction; Prospective Studies; Quality of Life; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarct
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Captopril; Cardiovascular Diseases; Cause of Death; Heart Failure; Humans; Middle Aged; Morbidity; Mortality; Myocardial Infarction; Systole; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Captopril; Cardiac Output, Low; Female; Humans; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Survival Analysis; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2006 |
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Research Design; Risk Factors; Stroke Volume; Survival Analysis; Survivors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2007 |
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.
Topics: Aged; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Creatinine; Diabetes Complications; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Risk Factors; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators.
Topics: Adrenergic beta-Antagonists; Captopril; Cardiac Catheterization; Coronary Vessels; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Prospective Studies; Stroke Volume; Survival Analysis; Time Factors; Vascular Patency; Ventricular Dysfunction, Left | 1995 |
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Topics: Administration, Oral; Aged; Aldosterone; Captopril; Cross-Over Studies; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Natriuresis; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Sodium; Ultrasonography; Ventricular Dysfunction, Left | 1995 |
Mechanistic lessons from the SAVE Study. Survival and Ventricular Enlargement.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Humans; Myocardial Infarction; Recurrence; Survival Analysis; Ventricular Dysfunction, Left | 1994 |
Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril and Thrombolysis Study (CATS).
Topics: Captopril; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Female; Humans; Hypotension; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Norepinephrine; Radionuclide Ventriculography; Streptokinase; Thrombolytic Therapy; Ventricular Dysfunction, Left | 1994 |
Left ventricular volume in thrombolysed patients with acute anterior myocardial infarction: the effect of captopril and xamoterol.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Volume; Cardiotonic Agents; Dilatation, Pathologic; Double-Blind Method; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Placebos; Prospective Studies; Stroke Volume; Thrombolytic Therapy; Ventricular Dysfunction, Left; Ventricular Function, Left; Xamoterol | 1995 |
Effects of cardiac versus circulatory angiotensin-converting enzyme inhibition on left ventricular diastolic function and coronary blood flow in hypertrophic obstructive cardiomyopathy.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Hypertrophic; Coronary Circulation; Diastole; Echocardiography; Enalaprilat; Female; Heart; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Prospective Studies; Ventricular Dysfunction, Left | 1998 |
Limitation of left ventricular hypertrophy and dysfunction by ACE inhibition after anterior Q-wave myocardial infarction.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Double-Blind Method; Echocardiography; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Ultrasonography, Doppler; Vasodilator Agents; Ventricular Dysfunction, Left | 1998 |
Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
Topics: Adult; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prospective Studies; Single-Blind Method; Vasodilator Agents; Ventricular Dysfunction, Left | 1998 |
[The CAPITOL study (Captopril Post Infarction Tolerance). A trial of progressive titration of captopril after myocardial infarct with left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Aged; Captopril; Drug Tolerance; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left | 1999 |
Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Echocardiography; Female; Heart Failure; Humans; Hypertension; Hypotension, Orthostatic; Indoles; Male; Myocardial Ischemia; Patient Dropouts; Perindopril; Time Factors; Ventricular Dysfunction, Left | 1999 |
Effects of early captopril therapy after myocardial infarction on the incidence of late potentials.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
Acute blood pressure response to trandolapril and captopril in patients with left ventricular dysfunction after acute myocardial infarction.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left | 2002 |
A comparative study of the first dose hypotensive effects of captopril and perindopril in patients with heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Hypotension; Male; Middle Aged; Perindopril; Ventricular Dysfunction, Left | 2001 |
48 other study(ies) available for captopril and Left Ventricular Dysfunction
Article | Year |
---|---|
Captopril inhibits calpain‑mediated apoptosis of myocardial cells in diabetic rats and improves cardiac function.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Calpain; Captopril; Caspase 3; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression Regulation; Heart; Humans; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats; Ventricular Dysfunction, Left | 2018 |
Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echocardiography; Heart Failure; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Nifedipine; Random Allocation; Rats, Inbred SHR; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Systole; Ventricular Dysfunction, Left | 2016 |
Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Early Medical Intervention; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Ramipril; Randomized Controlled Trials as Topic; Recovery of Function; Retrospective Studies; Risk Factors; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Diastole; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dystrophin; Gene Expression Regulation; Glucocorticoids; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sarcolemma; Treatment Outcome; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left | 2009 |
Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats.
Topics: Animals; Benzimidazoles; Benzoates; Captopril; Drug Therapy, Combination; Fibrosis; Gene Expression Regulation, Enzymologic; Isoproterenol; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Random Allocation; Rats; Rats, Wistar; Telmisartan; Ventricular Dysfunction, Left | 2010 |
Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
Topics: Age Factors; Aged; Aged, 80 and over; Alabama; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output, Low; Cardiology; Drug Utilization; Enalapril; Female; Hospitalization; Humans; Logistic Models; Male; Odds Ratio; Referral and Consultation; Retrospective Studies; Ventricular Dysfunction, Left | 2002 |
[Suboptimal results of Optimaal: treatment with ACE inhibitors remains the preferred therapy in patients with left ventricular dysfunction after acute myocardial infarct]].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Female; Humans; Length of Stay; Losartan; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
The OPTIMAAL study, not so optimal: the lessons of LIFE, RENAAL and IDNT.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
Topics: Aged; Angiotensin Receptor Antagonists; Captopril; Double-Blind Method; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptide Fragments; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Effects of acute angiotensin-converting enzyme inhibition on diastolic ventricular interaction in the dilated heart.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiomyopathy, Dilated; Diastole; Echocardiography, Doppler; Follow-Up Studies; Heart Rate; Heart Ventricles; Humans; Italy; Middle Aged; Mitral Valve; Observer Variation; Regional Blood Flow; Statistics as Topic; Stroke Volume; Systole; Tilt-Table Test; Time Factors; Treatment Outcome; Tricuspid Valve; Ventricular Dysfunction, Left | 2003 |
Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Valsartan an alternative to ACE inhibitor in high-risk MI.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
[When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Valsartan, captopril, or both in myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Ethics, Clinical; Heart Failure; Humans; Myocardial Infarction; Placebos; Research Design; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
VALIANT and EUROPA.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Valsartan in acute myocardial infarction trial.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Male; Myocardial Infarction; Tetrazoles; Valine; Ventricular Dysfunction, Left | 2004 |
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial).
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Echocardiography; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left; Ventricular Remodeling | 2004 |
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Comorbidity; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Life Tables; Male; Medical Records; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Stroke; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
Topics: Age Distribution; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benchmarking; Captopril; Cohort Studies; Contraindications; Creatinine; Dose-Response Relationship, Drug; Drug Utilization; Female; Guideline Adherence; Heart Failure; Hospital Mortality; Hospitalization; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Multivariate Analysis; United States; Vasodilator Agents; Ventricular Dysfunction, Left | 2005 |
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Topics: Aged; Captopril; Drug Therapy, Combination; Female; Humans; Internationality; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2006 |
[Isolated non-compaction of the left ventricular myocardium in a neonate--a case report].
Topics: Antihypertensive Agents; Captopril; Cardiotonic Agents; Echocardiography; Heart Defects, Congenital; Heart Failure; Humans; Infant, Newborn; Male; Medigoxin; Myocardium; Shock, Cardiogenic; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Left bundle branch block is not good for your heart.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Heart Failure; Humans; Myocardial Infarction; Risk Factors; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2007 |
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
From black and white to shades of gray: race and renin-angiotensin system blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Captopril; Heart Failure; Humans; Myocardial Infarction; Renin-Angiotensin System; Tetrazoles; United States; Valine; Valsartan; Ventricular Dysfunction, Left; White People | 2008 |
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Black or African American; Captopril; Female; Heart Failure; Hospitalization; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Systole; Tetrazoles; United States; Valine; Valsartan; Ventricular Dysfunction, Left; White People | 2008 |
Dosage of angiotensin converting enzyme inhibitors.
Topics: Captopril; Drug Administration Schedule; Humans; Ventricular Dysfunction, Left | 1995 |
[Exercise capacity evaluation in patients with mild to moderate left ventricular dysfunction. Influence of captopril].
Topics: Adult; Captopril; Clinical Protocols; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Time Factors; Ventricular Dysfunction, Left; Walking | 1995 |
Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on ventricular remodeling, function, mass and collagen.
Topics: Animals; Captopril; Collagen; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Ventricular Dysfunction, Left; Ventricular Function, Left | 1995 |
Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in The Netherlands.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output, Low; Cardiovascular Diseases; Computer Simulation; Cost-Benefit Analysis; Drug Costs; Humans; Models, Theoretical; Mortality; Netherlands; Preventive Medicine; Ventricular Dysfunction, Left | 1996 |
ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Echocardiography; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Signal Processing, Computer-Assisted; Ventricular Dysfunction, Left | 1996 |
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Ventricular Dysfunction, Left | 1997 |
Beta-adrenergic blocking agents or angiotensin-converting enzyme inhibitors, or both, for postinfarction patients with left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Humans; Myocardial Infarction; Neurotransmitter Agents; Survival Rate; Ventricular Dysfunction, Left | 1997 |
Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Body Weight; Captopril; Collagen; Cross-Linking Reagents; Diastole; Disease Models, Animal; Hydralazine; Hypertension; Male; Myocardium; Organ Size; Phenotype; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Solubility; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 1997 |
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Diastole; Female; Free Radical Scavengers; Guinea Pigs; Heart Ventricles; Hemoglobins; Isoquinolines; Lisinopril; Male; Muscle Relaxation; Nitric Oxide; Receptor, Bradykinin B2; Simethicone; Stroke Volume; Sulfhydryl Compounds; Superoxide Dismutase; Systole; Tetrahydroisoquinolines; Ventricular Dysfunction, Left | 1997 |
The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiopulmonary Bypass; Cardiovascular Diseases; Cardiovascular Surgical Procedures; Case-Control Studies; Electrocardiography; Enalapril; Female; Follow-Up Studies; Hospital Mortality; Humans; Incidence; Intra-Aortic Balloon Pumping; Lisinopril; Male; Middle Aged; Multiple Organ Failure; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Treatment of advanced heart failure in a young man with familial cardiomyopathy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Cardiomyopathy, Dilated; Hemodynamics; Humans; Male; Ventricular Dysfunction, Left | 1998 |
The role of endothelin-1 in the aorta of post-infarct left ventricular dysfunction rats treated with captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Endothelin-1; Hemodynamics; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 1998 |
Myocardial effects of beta-agonist stimulation in rats with chronic left ventricular dysfunction treated with an angiotensin-converting enzyme inhibitor.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chronic Disease; Heart; Hemodynamics; Male; Papillary Muscles; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Ventricular Dysfunction, Left | 1999 |
All that glitters is not gold.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left | 2000 |
Left ventricular dysfunction: causes, natural history, and hopes for reversal.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Female; Heart; Heart Failure; Humans; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Randomized Controlled Trials as Topic; Spironolactone; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Body Weight; Captopril; Collagen; Constriction, Pathologic; Disease Models, Animal; Echocardiography; Hydroxyproline; Hypertrophy, Left Ventricular; In Vitro Techniques; Isoproterenol; Male; Myocardium; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Regression Analysis; Systole; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
[ACE inhibition in patients with myocardial infarct and ventricular dysfunction: inappropriate application of therapy standards in patient samples].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Confidence Intervals; Echocardiography; Enalapril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Practice Guidelines as Topic; Ramipril; Registries; Sampling Studies; Surveys and Questionnaires; Time Factors; Ventricular Dysfunction, Left | 2001 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Reversibility of ventricular dysfunction. Clinical experience in a medical office.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Digoxin; Diuretics; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
[Effect of captopril on left ventricular diastolic dysfunction in young insulin dependent diabetic patients with microalbuminuria].
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diastole; Female; Humans; Male; Prospective Studies; Ventricular Dysfunction, Left | 2002 |